One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Editorial Board
doi : 10.1016/S1542-3565(23)00808-X
Volume 21, Issue 13, December 2023, Pages A9-A10
Table of Contents
doi : 10.1016/S1542-3565(23)00809-1
Volume 21, Issue 13, December 2023, Pages A13-A16
Elsewhere in the AGA Journals
doi : 10.1016/S1542-3565(23)00810-8
Volume 21, Issue 13, December 2023, Pages A25-A27
Traction Method Using Multiloop Traction Device for Duodenal Tumor With Scarring
Kazuhiro Yamamoto, Atsushi Goto, and Taro Takami
doi : 10.1016/j.cgh.2023.06.029
Volume 21, Issue 13, December 2023, Pages A31-A32
Double Balloon Enteroscopy Guided Band Ligation and Auto-Amputation for Treatment of a Large Hemorrhagic Lymphangioma
Rachel Hannum, Asif Khalid, and Charles Gabbert
doi : 10.1016/j.cgh.2023.07.010
Volume 21, Issue 13, December 2023, Pages A41-A42.e1
A Rare Cause of Quincke's Triad
Elia Armellini, 1 Francesca Besana, 2 and Flavio Metelli
doi : 10.1016/j.cgh.2023.07.011
Volume 21, Issue 13, December 2023, Page A43
Blue Notes
CHARLES J. KAHI, MD, MS,
doi : 10.1016/j.cgh.2023.09.019
Volume 21, Issue 13, December 2023, Pages 3201-3202
American Indian and Alaska Native Digestive Health: Challenges, Opportunities, and a Path Forward
TYSON A. BURNINGHAMLUKEJOHN W. DAY
doi : 10.1016/j.cgh.2023.09.006
Volume 21, Issue 13, December 2023, Pages 3203-3208
Advancing Health Equity in Gastroenterology Training Programs: Moving Beyond Training Modules to Meaningful Integration
ANDREA EWING REID
doi : 10.1016/j.cgh.2023.06.012
Volume 21, Issue 13, December 2023, Pages 3209-3212
Delivering High-Quality, Efficient Gastroenterology Care to Vulnerable and Underserved Populations: Special Considerations and Possible Solutions
Shreya Patel, 1,2 Justin L. Sewell, 1,2 Taft Bhuket, 3,4 and Ma Somsouk
doi : 10.1016/j.cgh.2023.08.007
Volume 21, Issue 13, December 2023, Pages 3213-3216.e1
Cannabinoids and the Gastrointestinal Tract
Michael Camilleri and Ting Zheng
doi : 10.1016/j.cgh.2023.07.031
Volume 21, Issue 13, December 2023, Pages 3217-3229
Biologics in the Treatment of Eosinophilic Esophagitis: Ready for Use?
Diana L. Snyder 1 and Evan S. Dellon
doi : 10.1016/j.cgh.2023.07.025
Volume 21, Issue 13, December 2023, Pages 3230-3233
Gastric Cancer Trends in the United States: In Context and Possible Explanations
MIMI C. TANDOUGLAS R. MORGAN
doi : 10.1016/j.cgh.2023.04.008
Volume 21, Issue 13, December 2023, Pages 3234-3235
Colorectal Cancer Risk Prediction to Tailor Screening: Will We Embrace It or KISS It Goodbye?
URI LADABAUMCYNTHIA W. KO
doi : 10.1016/j.cgh.2023.04.010
Volume 21, Issue 13, December 2023, Pages 3236-3237
Endoscopy Unit Level Interventions to Improve Adenoma Detection Rate: A Systematic Review and Meta-Analysis
Anshul Arora, 1 Cassandra McDonald, 1 Leonardo Guizzetti, 2 Alla Iansavichene,3 Mayur Brahmania, 1,4 Nitin Khanna, 1 Aze Wilson, 1,4,5,6 Vipul Jairath, 1,4,7 and Michael Sey
doi : 10.1016/j.cgh.2023.03.049
Volume 21, Issue 13, December 2023, Pages 3238-3257
Long-term Risks of Recurrence After Hospital Discharge for Acute Lower Gastrointestinal Bleeding: A Large Nationwide Cohort Study
Yoshinori Sato, 1, * Tomonori Aoki, 2, * Eiji Sadashima, 3 Yusuke Nakamoto, 1 Katsumasa Kobayashi, 4 Atsushi Yamauchi, 5 Atsuo Yamada, 2 Jun Omori, 6 Takashi Ikeya, 7 Taiki Aoyama, 8 Naoyuki Tominaga, 9 Takaaki Kishino, 10 Naoki Ishii, 11 Tsunaki Sawada, 12 Masaki Murata, 13 Akinari Takao, 14 Kazuhiro Mizukami, 15 Ken Kinjo, 16 Shunji Fujimori, 17 Takahiro Uotani, 18 Minoru Fujita, 19 Hiroki Sato, 20 Sho Suzuki, 21 Toshiaki Narasaka, 22,23 Junnosuke Hayasaka, 24 Tomohiro Funabiki, 25,26 Yuzuru Kinjo, 27 Akira Mizuki, 28 Shu Kiyotoki, 29 Tatsuya Mikami, 30 Ryosuke Gushima, 31 Hiroyuki Fujii, 32 Yuta Fuyuno, 33 Naohiko Gunji, 34 Yosuke Toya, 35 Kazuyuki Narimatsu, 36 Noriaki Manabe, 37 Koji Nagaike, 38 Tetsu Kinjo, 39 Yorinobu Sumida, 40 Sadahiro Funakoshi, 41 Kiyonori Kobayashi, 42 Tamotsu Matsuhashi, 43 Yuga Komaki, 44,45 Tadateru Maehata, 1 Keisuke Tateishi, 1 Mitsuru Kaise, 6 and Naoyoshi Nagata 46
doi : 10.1016/j.cgh.2023.05.021
Volume 21, Issue 13, December 2023, Pages 3258-3269.e6
Global Incidence and Prevalence of Eosinophilic Esophagitis, 1976–2022: A Systematic Review and Meta-analysis
Jong Woo Hahn,1,2 Kwanjoo Lee,3 Jae Il Shin,4 Seong Ho Cho,5 Stephen Turner,6 Jung U Shin,7 Abdullah ?zgür Yeniova,8 Ai Koyanagi,9,10 Louis Jacob,9,11 Lee Smith,12 Guillaume Fond,13,14 Laurent Boyer,13,14 Seung Won Lee,15 Rosie Kwon,16,17 Soeun Kim,17 Youn Ho Shin,18 Sang Youl Rhee,17,19 Jin Soo Moon,1 Jae Sung Ko,1 Dong Keon Yon,17,20 and Nikolaos G. Papadopoulos
doi : 10.1016/j.cgh.2023.06.005
Volume 21, Issue 13, December 2023, Pages 3270-3284.e77
Epidemiology of Gastric Malignancies 2000–2018 According to Histology: A Population-Based Analysis of Incidence and Temporal Trends
Sheila D. Rustgi, 1 Meg McKinley, 2,3 Brandon McBay, 4 Haley M. Zylberberg, 1 Scarlett L. Gomez, 3,5 Chin Hur, 1 Fay Kastrinos, 1 Samir Gupta, 6,7 Michelle Kang Kim, 8 Steven H. Itzkowitz, 8 and Shailja C. Shah
doi : 10.1016/j.cgh.2023.01.037
Volume 21, Issue 13, December 2023, Pages 3285-3295.e8
Risk Stratification Model for Hepatocellular Cancer in Patients With Cirrhosis
Fasiha Kanwal, 1,2,3 Saira Khaderi, 1 Amit G. Singal, 4 Jorge A. Marrero, 4 Sumeet K. Asrani, 5 Christopher I. Amos, 6 Aaron P. Thrift, 6 Jennifer R. Kramer, 2,3 Xian Yu, 2,3 Yumei Cao, 2,3 Michelle Luster, 1 Abeer Al-Sarraj, 1,2,3 Jing Ning, 7 and Hashem B. El-Serag
doi : 10.1016/j.cgh.2023.04.019
Volume 21, Issue 13, December 2023, Pages 3296-3304.e3
Utilization of Antiviral Therapy for Patients With Hepatitis B–Related Hepatocellular Carcinoma: A Nationwide Real-World US Study
Sahith Kudaravalli, 1,2, * Leslie Y. Kam, 1, * Daniel Q. Huang, 4,5 Ramsey Cheung, 1,6 and Mindie H. Nguyen
doi : 10.1016/j.cgh.2023.04.020
Volume 21, Issue 13, December 2023, Pages 3305-3313.e4
Impact of PNPLA3 rs738409 Polymorphism on the Development of Liver-Related Events in Patients With Nonalcoholic Fatty Liver Disease
Chiara Rosso, 1 Gian Paolo Caviglia, 1 Giovanni Birolo, 1 Angelo Armandi, 1,2 Grazia Pennisi, 3 Serena Pelusi, 4 Ramy Younes, 5 Antonio Liguori, 6 Nuria Perez-Diaz-del-Campo, 1 Aurora Nicolosi, 1 Olivier Govaere, 7 Gabriele Castelnuovo, 1 Antonella Olivero, 1 Maria Lorena Abate, 1 Davide Giuseppe Ribaldone, 1 Piero Fariselli, 1 Luca Valenti, 4,8 Luca Miele, 6,9 Salvatore Petta, 3 Manuel Romero-Gomez, 10 Quentin M. Anstee, 7,11 and Elisabetta Bugianesi
doi : 10.1016/j.cgh.2023.04.024
Volume 21, Issue 13, December 2023, Pages 3314-3321.e3
Fibrosis-4 Index Predicts Long-Term All-Cause, Cardiovascular and Liver-Related Mortality in the Adult Korean Population
Young-Gyun Seo, 1 Stergios A. Polyzos, 2 Kyung-Hee Park, 1 and Christos S. Mantzoros
doi : 10.1016/j.cgh.2023.04.026
Volume 21, Issue 13, December 2023, Pages 3322-3335
Secondary Prevention of Esophageal Variceal Bleeding Is Often Imperfect: A National, Population-Based Cohort Study of 3592 Patients
Hannes Hagstr?m, 1,2 Ying Shang, 2 Elliot B. Tapper, 3 Axel Wester, 2 and Linnea Widman
doi : 10.1016/j.cgh.2023.05.003
Volume 21, Issue 13, December 2023, Pages 3336-3345.e2
Risk of Severe Infection in Patients With Biopsy-proven Nonalcoholic Fatty Liver Disease – A Population-based Cohort Study
Fahim Ebrahimi, 1,2 Tracey G. Simon, 1,3,4,5 Hannes Hagstr?m, 6,7 Jonas S?derling, 1,8 Axel Wester, 7 Bjorn Roelstraete, 1 and Jonas F. Ludvigsson
doi : 10.1016/j.cgh.2023.05.013
Volume 21, Issue 13, December 2023, Pages 3346-3355.e19
Patients With Microscopic Colitis Are at Higher Risk of Major Adverse Cardiovascular Events: A Matched Cohort Study
Anders Forss, 1,2 David Bergman, 1 Bjorn Roelstraete, 1 Johan Sundstr?m, 3,4 Ali Mahdi, 5 Hamed Khalili, 6,7,8,9 and Jonas F. Ludvigsson
doi : 10.1016/j.cgh.2023.05.014
Volume 21, Issue 13, December 2023, Pages 3356-3364.e9
Adalimumab in Biologic-naïve Patients With Crohn’s Disease After Resolution of an Intra-abdominal Abscess: A Prospective Study From the GETAID
Yoram Bouhnik, 1 Guillaume Pineton de Chambrun, 2 Jérôme Lambert, 3 Maria Nachury, 4 Philippe Seksik, 5 Romain Altwegg, 6 Lucine Vuitton, 7 Carmen Stefanescu, 1 Stéphane Nancey, 8 Alexandre Aubourg, 9 Mélanie Serrero, 10 Jérôme Filippi, 11 Kristell Desseaux, 3 Stéphanie Viennot, 12 Vered Abitbol, 13 Madina Boualit, 14 Arnaud Bourreille, 15 Cyrielle Giletta, 16 Anthony Buisson, 17 Xavier Roblin, 18 Nina Dib, 19 Georgia Malamut, 13 Aurélien Amiot, 20 Mathurin Fumery, 21 Edouard Louis, 22 Yasmine Elgharabawy,23 and Laurent Peyrin-Biroulet, 24 for the MICA-GETAID Study Group
doi : 10.1016/j.cgh.2023.01.013
Volume 21, Issue 13, December 2023, Pages 3365-3378.e5
Incidence of Inflammatory Bowel Disease in Urban China: AÂ Nationwide Population-based Study
Lu Xu, 1,2 Bingjie He, 3 Yexiang Sun, 4 Jun Li,5 Peng Shen, 4 Liming Hu, 4 Guozhen Liu, 6 Jinxi Wang, 7 Liping Duan, 5 Siyan Zhan,1,2,8,9 and Shengfeng Wang
doi : 10.1016/j.cgh.2023.08.013
Volume 21, Issue 13, December 2023, Pages 3379-3386.e29
Delayed Ustekinumab Responders in Ulcerative Colitis Have Greater Inflammatory Burden but Similar Outcomes as Early Responders
Emily C. L. Wong, 1 Parambir S. Dulai, 2 John K. Marshall, 1 Vipul Jairath,3 Walter Reinisch,4 and Neeraj Narula
doi : 10.1016/j.cgh.2023.06.011
Volume 21, Issue 13, December 2023, Pages 3387-3396.e1
A Diagnosis of Irritable Bowel Syndrome Using Rome IV Criteria and Limited Investigations is Durable in Secondary Care
Mais Khasawneh, 1 Orla F. Craig, 1 David J. Gracie, 1 Christopher J. Black, 1,2, * and Alexander C. Ford
doi : 10.1016/j.cgh.2023.05.022
Volume 21, Issue 13, December 2023, Pages 3397-3404.e1
A Randomized, Controlled Trial of Efficacy and Safety of Cannabidiol in Idiopathic and Diabetic Gastroparesis
Ting Zheng, 1 Joelle BouSaba, 1 Ann Taylor, 1 Saam Dilmaghani,1 Irene Busciglio, 1 Paula Carlson, 1 Monique Torres, 1 Michael Ryks,1 Duane Burton, 1 William Scott Harmsen, 2 and Michael Camilleri
doi : 10.1016/j.cgh.2023.07.008
Volume 21, Issue 13, December 2023, Pages 3405-3414.e4
Risk-Stratified Screening for Colorectal Cancer Using Genetic and Environmental Risk Factors: A Cost-Effectiveness Analysis Based on Real-World Data
Rosita van den Puttelaar, 1 Reinier G. S. Meester, 1 Elisabeth F. P. Peterse, 1,2 Ann G. Zauber, 3 Jiayin Zheng, 2 Richard B. Hayes, 4 Yu-Ru Su, 2,5 Jeffrey K. Lee,6,7 Minta Thomas, 2 Lori C. Sakoda, 2,6 Yi Li, 2 Douglas A. Corley, 6,7 Ulrike Peters, 2 Li Hsu, 2 and Iris Lansdorp-Vogelaar
doi : 10.1016/j.cgh.2023.03.003
Volume 21, Issue 13, December 2023, Pages 3415-3423.e29
Colorectal Cancer Stage Distribution at First and Repeat Fecal Immunochemical Test Screening
Arthur Kooyker, 1,2 Lucie de Jonge, 1 Esther Toes-Zoutendijk, 1 Manon Spaander, 3 Hanneke van Vuuren, 3 Ernst Kuipers, 3 Folkert van Kemenade, 4 Chris Ramakers, 5 Evelien Dekker, 6 Iris Nagtegaal, 7 Monique van Leerdam, 2,8 and Iris Lansdorp-Vogelaar
doi : 10.1016/j.cgh.2023.07.028
Volume 21, Issue 13, December 2023, Pages 3424-3432.e2
Net Remission Rates with Biologic and Small Molecule Treatment in Ulcerative Colitis: A Reappraisal of the Clinical Trial Data
MAIA KAYAL HANNAH POSNERELIZABETH SPENCER
doi : 10.1016/j.cgh.2023.01.005
Volume 21, Issue 13, December 2023, Pages 3433-3436.e1
Validation of the Model for End-Stage Liver Disease 3.0 in Korean Patients on the Liver Transplant Waiting List
JIWON YANG * JUNG-BIN PARK * JU HYUN SHIM YOUNG-SUK LIM HAN CHU LEE JONGGI CHOI
doi : 10.1016/j.cgh.2023.01.020
Volume 21, Issue 13, December 2023, Pages 3437-3439.e1
Geographic Variation in NAFLD Prevalence and Subspecialty Care Utilization Among Insured Adults in the United States
SEREN M. GEDALLOVICHJOHN STEPHEN RAYMOND KANG RONALD T. ACKERMANNDANIELA P. LADNERLISA B. VANWAGNER
doi : 10.1016/j.cgh.2023.01.010
Volume 21, Issue 13, December 2023, Pages 3440-3443.e2
Physical Activity Intensity, Genetic Predisposition, and Risk of Nonalcoholic Fatty Liver Disease: A Prospective Cohort Study
MENGYUN LUO
doi : 10.1016/j.cgh.2023.01.011
Volume 21, Issue 13, December 2023, Pages 3444-3447.e2
Evaluation of Tofacitinib in Primary Sclerosing Cholangitis and Associated Colitis: A Multicenter, Retrospective Study
IDA SCHREGEL
doi : 10.1016/j.cgh.2023.01.014
Volume 21, Issue 13, December 2023, Pages 3448-3450.e3
Sodium-glucose Cotransporter-2 Inhibitors and Risk of Hepatocellular Carcinoma Among Patients With Type 2 Diabetes
doi : 10.1016/j.cgh.2023.01.031
Volume 21, Issue 13, December 2023, Pages 3451-3454.e4
Terlipressin Treatment Is Associated With Reversal of Hepatorenal Syndrome in Patients With Alcoholic Hepatitis
doi : 10.1016/j.cgh.2023.02.015
Volume 21, Issue 13, December 2023, Pages 3455-3457.e3
Helicobacter pylori Antimicrobial Resistance in a Pediatric Population From the New England Region of the United States
doi : 10.1016/j.cgh.2023.02.026
Volume 21, Issue 13, December 2023, Pages 3458-3460.e2
Exam 1: Endoscopy Unit Level Interventions to Improve Adenoma Detection Rate: A Systematic Review and Meta-Analysis
doi : 10.1016/j.cgh.2023.09.020
Volume 21, Issue 13, December 2023, Pages e53-e54
Diverticulosis and Hemorrhoids: Fact or Artefact?
NADIA FATHALLAH LUCAS SPINDLER VINCENT DE PARADES
doi : 10.1016/j.cgh.2023.03.038
Volume 21, Issue 13, December 2023, Page 3461
Reply
JARED A. SNINSKYROBERT S. SANDLERANNE F. PEERY
doi : 10.1016/j.cgh.2023.05.010
Volume 21, Issue 13, December 2023, Pages 3461-3462
Efficacy of Mesalamine in Irritable Bowel Syndrome
doi : 10.1016/j.cgh.2023.03.021
Volume 21, Issue 13, December 2023, Pages 3462-3463
Multicancer Early Detection
doi : 10.1016/j.cgh.2023.03.039
Volume 21, Issue 13, December 2023, Page 3464
Clinical Outcomes in Nonalcoholic Fatty Liver Disease
doi : 10.1016/j.cgh.2023.02.030
Volume 21, Issue 13, December 2023, Page 3466
